Highlighting innovation

In the quest to revolutionise cancer diagnosis, BioMavericks emerged amidst the COVID-19 crisis, recognizing a crucial gap in advanced sequencing methods for cancer detection. Their ground-breaking in vitro diagnostic tool, fuelled by proprietary biomarkers, with a sensitivity and specificity of over 97% promises exceptional accuracy in detecting prevalent cancers.

George William Ssendagala

March 6, 2024

Microneedle Solutions (MNS) is on a quest to increase vaccines uptake by manufacturing affordable self-adhesive vaccine patches that patients can use themselves. The self-administration means that, ultimately, MNS’s product can reduce the strain on healthcare systems and increase vaccine uptake, thus reducing health inequality whilst improving access to vaccines globally.

Ana Ivanus

January 31, 2024

Pear Bio is revolutionising the way cancer treatments are assigned to patients. They have developed a functional precision medicine platform by integrating tissue engineering, confocal microscopy, and computer vision into a single patient stratification tool. This facilitates the assessment of the treatment efficacy in the human tumour microenvironment by modelling the impact a drug or a combination of drugs has on the progression of disease.

December 4, 2023

The biomanufacturing industry is currently experiencing a ground-breaking transformation driven by the integration of AI and new technologies that make high-throughput engineering possible. This paradigm shift has not only pushed the boundaries of biological capabilities, but has also prompted several companies to challenge traditional biomanufacturing methods. Among them, Eden Bio stands out with its bold ambition to redesign and optimise the process for unprecedented efficiency.

October 24, 2023

Greenhouse gases such as carbon dioxide (CO2) and methane (CH4), together with carbon monoxide (CO), methanol (CH3OH), and formate (HCOOH), form a class of molecules classified as one-carbon (C1) compounds. From a fundamental point of view, carbon is a necessary building block for many commonplace goods, such as biofuels, medicines, and packaging materials. It has been argued that a circular bioeconomy should eliminate, effectively utilise, and sequester more carbon than it emits into the atmosphere.

George William Ssendagala

September 25, 2023

Synthetic biology has grown tremendously popular in recent years, following successes from the realms of gene therapies to sustainable agriculture and much more. Our next guest on the SEC series truly embodies the ‘dogma breaking’ aspect of synthetic biology, targeting the inside of our cells through their start-up NanoSyrinx.

Charles Leach

September 15, 2023

‍London, September 2023 - The Innovators Club, a network accelerator programme run by the non-profit Science Entrepreneur Club (SEC), has today announced its fourth cohort welcoming six start-ups innovating across the life sciences.

September 14, 2023

The first period tracking app was released in 2013, and approximately 100 million people use a period tracking app today. With this growth, over 10 years, period tracking apps seem like an exponential success. Yet, every month, around 1.8 billion people in the global population menstruate, suggesting there is a side of the market that is currently being unfulfilled.

Natasha Barrow

May 31, 2023

Currently based at the University of Sheffield in the Chemical and Biological Engineering department, Evolutor was created following the amazing work of Prof. Tuck Seng Wong and Dr Kang Lan Tee, through which CEO, Joe Price, envisioned the evolutionary microbe development company: Evolutor. Evolutor’s Accelerated Evolution Platform allows them to use the power of adaptive evolution to create improved microbes for industrial usage. With this platform, their ambition is to build the world’s first evolutionary bio-foundry...

April 21, 2023

Unaffordable, imprecise, and an untimely disease diagnosis undermines the global healthcare system, contributing to increased morbidity and mortality. The rising prevalence of diseases such as cancer and neurological disorders need a timely diagnosis for better management. New drug therapies for chronic diseases are needed and being developed, but currently, the cost of development through screening and trials of compounds is prohibitive, restricting patient access. Through their novel technology, ChronosDx is developing a promising bioassay to circumvent these challenges.

George William Ssendagala

March 23, 2023